Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
6.54
-0.14 (-2.10%)
Nov 20, 2024, 4:00 PM EST - Market closed
Annovis Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 6.5 | 6.24 | 9 | 6.06 | 3.59 | 0.83 | |
| Research & Development | 23.9 | 38.79 | 16.52 | 8.48 | 3.05 | 0.78 | |
| Operating Expenses | 30.4 | 45.04 | 25.51 | 14.54 | 6.64 | 1.61 | |
| Operating Income | -30.4 | -45.04 | -25.51 | -14.54 | -6.64 | -1.61 | |
| Interest Expense | - | - | - | - | - | -0.04 | |
| Interest & Investment Income | 0.27 | 0.67 | 0.18 | 0.01 | 0.05 | - | |
| Other Non Operating Income (Expenses) | -10.81 | -11.84 | - | 0.04 | 1.13 | 0.66 | |
| Pretax Income | -40.94 | -56.2 | -25.33 | -14.49 | -5.46 | -0.99 | |
| Net Income | -40.94 | -56.2 | -25.33 | -14.49 | -5.46 | -0.99 | |
| Net Income to Common | -40.94 | -56.2 | -25.33 | -14.49 | -5.46 | -0.99 | |
| Shares Outstanding (Basic) | 11 | 9 | 8 | 8 | 6 | 0 | |
| Shares Outstanding (Diluted) | 11 | 9 | 8 | 8 | 6 | 0 | |
| Shares Change (YoY) | 28.48% | 10.55% | 7.03% | 20.88% | 2132.36% | 1.81% | |
| EPS (Basic) | -3.71 | -6.23 | -3.10 | -1.90 | -0.87 | -3.51 | |
| EPS (Diluted) | -3.97 | -6.23 | -3.10 | -1.90 | -0.87 | -3.51 | |
| Free Cash Flow | -22.97 | -39.97 | -17.31 | -9.13 | -3.97 | -0.48 | |
| Free Cash Flow Per Share | -2.08 | -4.43 | -2.12 | -1.20 | -0.63 | -1.69 | |
| EBIT | -30.4 | -45.04 | -25.51 | -14.54 | -6.64 | -1.61 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.